KALIVIR IMMUNOTHERAPEUTICS
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s cutting-edge, next generation oncolytic viral immunotherapy programs combine technologies developed in-house and licensed from University of Pittsburgh’s world-class oncolytic virus and immunotherapy research programs.
KALIVIR IMMUNOTHERAPEUTICS
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2019-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.kalivir.com
Total Employee:
11+
Status:
Active
Contact:
+1 412 435 6730
Email Addresses:
[email protected]
Total Funding:
0
Similar Organizations
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Employees Featured
Investors List
K Partners
K Partners investment in Series A - KaliVir Immunotherapeutics
QUAD Investment Management
QUAD Investment Management investment in Series A - KaliVir Immunotherapeutics
Premier Partners
Premier Partners investment in Series A - KaliVir Immunotherapeutics
Official Site Inspections
http://www.kalivir.com
- Host name: 167.0.153.160.host.secureserver.net
- IP address: 160.153.0.167
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
